XML 68 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Summary of Financial Information with Respect to Reportable Segments

Presented below is financial information with respect to the Company’s reportable segments for the years presented:

			Year Ended December 31,
			2024						2023						2022
Segment revenues:
Software			$	180,365					$	159,124					$	135,578
Drug discovery			27,174						57,542						45,377
Total segment revenues			207,539						216,666						180,955
Segment cost of revenues:
Software			36,900						29,514						29,576
Drug discovery			38,556						46,460						50,357
Total segment cost of revenues			75,456						75,974						79,933
Segment gross profit:
Software			143,465						129,610						106,002
Drug discovery			(11,382)						11,082						(4,980)
Total segment gross profit			132,083						140,692						101,022
Unallocated (expense) income:
Research and development			(201,785)						(181,766)						(126,372)
Sales and marketing			(39,917)						(37,226)						(30,642)
General and administrative			(99,677)						(99,148)						(90,825)
Gain on equity investments			—						147,213						11,825
Change in fair value			5,683						53,461						(18,084)
Other income			17,902						19,693						3,953
Income tax expense			(1,412)						(2,199)						(63)
Consolidated net (loss) income			$	(187,123)					$	40,720					$	(149,186)

Schedule of Revenues by Geographic Area

Revenues by geographic area are determined based on the address provided by the Company's customers and partners. The following table sets forth revenues by geographic area for the years ended December 31, 2024, 2023, and 2022:

			Year Ended December 31,
			2024						2023						2022
United States			$	114,869					$	161,961					$	123,556
APAC			25,802						24,569						21,680
EMEA			65,650						29,135						34,451
Rest of World			1,218						1,001						1,268
			$	207,539					$	216,666					$	180,955

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration